UK NHS appoints chair of new Commissioning Board
This article was originally published in Clinica
The UK Department of Health has appointed Malcolm Grant chair of the NHS Commissioning Board, the body that will oversee the delivery of healthcare services worth annually around £60bn ($95bn) under the reformed NHS.
You may also be interested in...
The FDA’s OPQ touts approval of sixth and seventh continuously manufactured drugs and quicker delivery of inspection results in latest annual report.
No device-related warning letters were released by the US FDA the week of 19 February.
Complex generics and value added medicines share common challenges on harmonization of regulation, lack of incentives and clarity of guidelines, heard delegates to Medicines for Europe’s Regulatory & Scientific Affairs conference.